Novel leads and drugs and their mechanism of action in the field of vector borne parasitic disease

The workshop “Novel leads and drugs and their mechanism of action in the field of vector borne parasitic disease” is jointly organized by WG1 “Compound libraries coordination and integration of compound design” and WG2 “Integration of early phase studies and low environmental impact actions” of the COST Action CA21111 OneHealthDrugs.
The focus of the workshop is to bring together experts to report and discuss common definitions of novel leads and drugs and their mechanisms of action in view also of their impact on OneHealth needs. The workshop will give an overview about the state of art in the field and will help to plan a roadmap to achieve basic objectives of the COST Action. This workshop is connected with WG1/WG2 activity based on the handling of chemical compound information and the usage of compound databases/repositories and WG3 activity on the profile of leads and drug candidate.

Speakers

Jean-Claude Dujardin (Institute of Tropical Medicine, Antwerp, BE)
Michael Boshart (Biocenter, University of Munich, DE)
John M. Kelly (London School of Hygiene and Tropical Medicine, UK)
Manfred Jung (Institute of Pharmaceutical Sciences, University of Freiburg, DE)
Aleksandar Cvetkovski (University "Goce Delcev" Stip, Faculty of Medical Science, Stip, MK)
Kayhan Ilbeigi (Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, BE)
Sébastien Pomel (Faculté de Pharmacie, Université Paris-Saclay, FR)
Katharina Possart (Institute for Pharmaceutical Biology and Phytochemistry, University of Münster, DE)
Najma Rachidi (Molecular Parasitology, Institut Pasteur, Paris, FR)

The event registration requires two steps :
1) create an e-COST account in the www.cost.eu and
2) register here: https://forms.gle/Xy9gNNsBDK4t9CDb8